# Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

> **NCT07192263** · PHASE3 · NOT_YET_RECRUITING · sponsor: **HK inno.N Corporation** · enrollment: 300 (estimated)

## Conditions studied

- Obesity &Amp; Overweight

## Interventions

- **DRUG:** IN-B00009
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07192263
- **Lead sponsor:** HK inno.N Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-22
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-09-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07192263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07192263, "Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07192263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*